XLerate's third class tackles clinical trials, medication adherence, oncology

By Jonah Comstock
11:47 am
Share

iClinicalLouisville, Kentucky-based XLerate Health has announced its latest class of seven startups. This is only the third cohort to go through XLerate's 13-week course, which kicks off August 3rd and runs through the end of October.

“We have a stellar set of teams, many of which have seasoned founders/entrepreneurs,” Bob Saunders, XLerateHealth’s chairman and co-founder, said in a statement. “We are extremely excited to begin helping these companies gain valuable insight through customer discovery and customer pilots which allow them to refine their business models based on intimate knowledge of customer pain points and market needs in order to ultimately accelerate their speed to market.”

XLerate startups receive an optional $20,000 stipend and office space in Louisville, as well as access to a mentor network that includes executives from health tech startups, insurers, hospitals and pharmaceutical companies. Through the mentors, XLerate promises “introductions and meetings with pilot customers, potential funders and potential acquirers.”

If companies take the $20,000, XLerate Health gets a 6 percent equity stake in the startup. Should they choose to forgo the stipend, the accelerator will take a 2 percent stake instead. XLerate's second class launched around this time last year.

Here are the seven startups in XLerate's newest class:

San Francisco-based iClinical is developing a mobile platform for data aggregation and data analytics in clinical trials. The software delivers data insights to researchers in near-real time and includes collaboration tools to make trials more efficient and bring drugs to market more quickly.

iPillBox, based in Louisville, is working on a mobile pill organizer designed to help patients with complicated medication schedules manage their compliance. It also allows caregivers and physicians to monitor whether a person is taking their pills, via a secure web application.

Inscope Medical Solutionsalso a Louisville local, has developed a "wifi-enabled multi-purpose, disposable laryngoscope that optimizes airway intubation by integrating several devices into one easy-to-use device," according to XLerate, which says laryngoscopes represent a $1.2 billion market.

Coming out of Toronto, MedUX is working on creating a tactile interface for surgeons operating in a sterile field. The technology allows surgeons access to their digital case data without having to scrub out.

NormaLyte, also from Louisville, is creating a sugar-free treatment for dehydration for patients and athletes based on a World Health Organization recommended formula.

Granger, Indiana-based SYSGenomics is developing molecular diagnostic tests to help oncologists and cancer patients choose the most effective treatment strategy for their specific diagnosis.

Trajectory Healthcare, based in Loveland, Ohio, is a population health analytics company focused on evaluating, improving and designing population health management programs. Trajectory offers user-friendly software to provider and payer customers to help them make more informed clinical and financial decisions.

Share